期刊文献+

肝纤维化生物标志物研究的进展 被引量:7

暂未订购
导出
摘要 在世界范围内,大约30亿人受乙型肝炎病毒威胁,3亿人感染慢性乙型肝炎,1.8亿人患慢性C型肝炎[1]。急性病毒性肝炎能进展到慢性,随后发展成肝纤维化,最终导致肝硬化,肝硬化可产生严重的并发症,可能需要肝移植,治疗费用昂贵,死亡率高。不幸的是,至今没有可利用的及有效的抗纤维化治疗。
作者 王继贵
出处 《实验与检验医学》 CAS 2011年第2期138-141,共4页 Experimental and Laboratory Medicine
  • 相关文献

参考文献2

二级参考文献44

  • 1Yukiko Saitou,Katsuya Shiraki,Yutaka Yamanaka,Yumi Yamaguchi,Tomoyuki Kawakita,Norihiko Yamamoto,Kazushi Sugimoto,Kazumoto Murata,Takeshi Nakano.Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease[J].World Journal of Gastroenterology,2005,11(4):476-481. 被引量:22
  • 2Forns X, Ampurdanes S, Sanchez-Tapias JM, Guilera M, Sans M, Sanchez-Fueyo A. Quinto L, Joya P, Bruguera M, Rodes J.Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center. J Hepatol 2001; 35:265-271.
  • 3Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, Hashimoto E, Lefkowitch JH, Ludwig J, Okuda K. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23; 1334-1340.
  • 4Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For thegroup of epidemiology of the french association for the study of the liver (AFEF). Hepatology 2000; 32:477-481.
  • 5Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatololgy 2003; 38:518-526.
  • 6Pares A, Deulofeu R, Gimenez A, Caballeria L, Bruguera M,Caballeria J, Ballesta AM, Rodes J. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatoloyg 1996; 24:1399-1403.
  • 7Nojgaard C, Johansen JS, Cl~ristensen E, Skovgaard LT, Price PA, Becker U. EMALD group. Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease. J Hepatol 2003; 2:179-186.
  • 8Nojgaard C,Johansen JS, Krarup HB, Holten-Andersen M,Moiler A, Bendtsen F. Effect of antiviral therapy on markers of fibrogenesis in patients with chronic hepatitis C. Scand J Gastroenterol 2003; 38:659-665.
  • 9Murawaki Y, Ikuta Y, Koda M, Yamada S, Kawasaki H. Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease. J Hepatol 1996; 24:148-154.
  • 10Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, Bruguera M, Sanchez-Tapias JM, Rodes J. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36:986-992.

共引文献24

同被引文献81

引证文献7

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部